Pathos AI Appoints Iker Huerga as Chief Executive Officer to Lead the Next Era of AI-Enabled Drug Development

New York, NY, May 8th, 2025 (GLOBE NEWSWIRE) — Pathos AI, (www.pathos.com), a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief Executive Officer and Board Member. Huerga brings over two decades of experience at the intersection of artificial intelligence and oncology drug development. He was most recently Chief Data Scientist for Oncology R&D at AstraZeneca and formerly Executive Vice President at Tempus Labs.